Annual Revenue
$442.74 M
+$32.14 M+7.83%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual revenue is $442.74 million, with the most recent change of +$32.14 million (+7.83%) on December 31, 2023.
- During the last 3 years, IRWD annual revenue has risen by +$53.21 million (+13.66%).
- IRWD annual revenue is now at all-time high.
Performance
IRWD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$91.59 M
-$2.80 M-2.97%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly revenue is $91.59 million, with the most recent change of -$2.80 million (-2.97%) on September 30, 2024.
- Over the past year, IRWD quarterly revenue has stayed the same.
- IRWD quarterly revenue is now -30.17% below its all-time high of $131.17 million, reached on September 30, 2019.
Performance
IRWD Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$378.42 M
-$22.15 M-5.53%
September 30, 2024
Summary
- As of February 20, 2025, IRWD TTM revenue is $378.42 million, with the most recent change of -$22.15 million (-5.53%) on September 30, 2024.
- Over the past year, IRWD TTM revenue has stayed the same.
- IRWD TTM revenue is now -14.53% below its all-time high of $442.74 million, reached on December 31, 2023.
Performance
IRWD TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
IRWD Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.8% | 0.0% | 0.0% |
| 3 y3 years | +13.7% | -21.8% | -8.5% |
| 5 y5 years | +27.7% | -21.8% | -8.5% |
IRWD Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.8% | -22.1% | +22.3% | -14.5% | at low |
| 5 y | 5-year | at high | +13.7% | -27.5% | +22.3% | -14.5% | at low |
| alltime | all time | at high | +4131.0% | -30.2% | +2713.9% | -14.5% | +7507.9% |
Ironwood Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $91.59 M(-3.0%) | $378.42 M(-5.5%) |
| Jun 2024 | - | $94.40 M(+26.1%) | $400.56 M(-3.1%) |
| Mar 2024 | - | $74.88 M(-36.3%) | $413.55 M(-6.6%) |
| Dec 2023 | $442.74 M(+7.8%) | $117.55 M(+3.4%) | $442.74 M(+2.4%) |
| Sep 2023 | - | $113.74 M(+5.9%) | $432.38 M(+1.2%) |
| Jun 2023 | - | $107.38 M(+3.2%) | $427.28 M(+2.4%) |
| Mar 2023 | - | $104.06 M(-2.9%) | $417.13 M(+1.6%) |
| Dec 2022 | $410.60 M(-0.8%) | $107.20 M(-1.3%) | $410.60 M(-2.4%) |
| Sep 2022 | - | $108.64 M(+11.7%) | $420.53 M(+1.2%) |
| Jun 2022 | - | $97.23 M(-0.3%) | $415.64 M(-1.6%) |
| Mar 2022 | - | $97.53 M(-16.7%) | $422.44 M(+2.1%) |
| Dec 2021 | $413.75 M(+6.2%) | $117.13 M(+12.9%) | $413.75 M(+0.1%) |
| Sep 2021 | - | $103.75 M(-0.3%) | $413.30 M(+0.1%) |
| Jun 2021 | - | $104.03 M(+17.1%) | $413.02 M(+3.7%) |
| Mar 2021 | - | $88.84 M(-23.9%) | $398.43 M(+2.3%) |
| Dec 2020 | $389.52 M(-9.1%) | $116.68 M(+12.8%) | $389.52 M(-2.4%) |
| Sep 2020 | - | $103.47 M(+15.7%) | $399.14 M(-6.5%) |
| Jun 2020 | - | $89.43 M(+11.9%) | $426.84 M(-2.9%) |
| Mar 2020 | - | $79.94 M(-36.7%) | $439.63 M(+2.6%) |
| Dec 2019 | $428.41 M(+23.6%) | $126.30 M(-3.7%) | $428.41 M(-1.0%) |
| Sep 2019 | - | $131.17 M(+28.3%) | $432.80 M(+17.8%) |
| Jun 2019 | - | $102.22 M(+48.7%) | $367.32 M(+6.1%) |
| Mar 2019 | - | $68.73 M(-47.4%) | $346.21 M(-0.1%) |
| Dec 2018 | $346.64 M(+16.2%) | $130.69 M(+99.0%) | $346.64 M(+11.8%) |
| Sep 2018 | - | $65.69 M(-19.0%) | $310.15 M(-6.4%) |
| Jun 2018 | - | $81.11 M(+17.3%) | $331.29 M(+5.1%) |
| Mar 2018 | - | $69.16 M(-26.6%) | $315.26 M(+5.7%) |
| Dec 2017 | $298.28 M(+8.9%) | $94.21 M(+8.5%) | $298.28 M(+2.3%) |
| Sep 2017 | - | $86.83 M(+33.4%) | $291.53 M(+7.7%) |
| Jun 2017 | - | $65.08 M(+24.7%) | $270.81 M(+4.1%) |
| Mar 2017 | - | $52.17 M(-40.4%) | $260.08 M(-5.1%) |
| Dec 2016 | $273.96 M | $87.46 M(+32.3%) | $273.96 M(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $66.11 M(+21.6%) | $239.81 M(+12.4%) |
| Jun 2016 | - | $54.35 M(-17.7%) | $213.27 M(+14.3%) |
| Mar 2016 | - | $66.04 M(+23.9%) | $186.66 M(+24.8%) |
| Dec 2015 | $149.56 M(+95.7%) | $53.31 M(+34.7%) | $149.56 M(+11.3%) |
| Sep 2015 | - | $39.57 M(+42.6%) | $134.32 M(+20.3%) |
| Jun 2015 | - | $27.74 M(-4.1%) | $111.67 M(+23.0%) |
| Mar 2015 | - | $28.93 M(-24.0%) | $90.76 M(+18.7%) |
| Dec 2014 | $76.44 M(+234.1%) | $38.07 M(+125.0%) | $76.44 M(+76.1%) |
| Sep 2014 | - | $16.92 M(+147.3%) | $43.39 M(+38.2%) |
| Jun 2014 | - | $6.84 M(-53.2%) | $31.41 M(-8.2%) |
| Mar 2014 | - | $14.61 M(+190.3%) | $34.23 M(+49.6%) |
| Dec 2013 | $22.88 M(-84.8%) | $5.03 M(+2.0%) | $22.88 M(-49.0%) |
| Sep 2013 | - | $4.93 M(-49.0%) | $44.83 M(-67.1%) |
| Jun 2013 | - | $9.66 M(+196.9%) | $136.31 M(-3.5%) |
| Mar 2013 | - | $3.25 M(-87.9%) | $141.25 M(-6.0%) |
| Dec 2012 | $150.25 M(+128.1%) | $26.98 M(-72.0%) | $150.25 M(-3.3%) |
| Sep 2012 | - | $96.41 M(+560.2%) | $155.42 M(+118.2%) |
| Jun 2012 | - | $14.60 M(+19.2%) | $71.22 M(+4.9%) |
| Mar 2012 | - | $12.25 M(-61.9%) | $67.88 M(+3.1%) |
| Dec 2011 | $65.87 M(+50.2%) | $32.15 M(+163.2%) | $65.87 M(+30.5%) |
| Sep 2011 | - | $12.22 M(+8.5%) | $50.49 M(+6.7%) |
| Jun 2011 | - | $11.26 M(+10.0%) | $47.33 M(+4.6%) |
| Mar 2011 | - | $10.24 M(-39.0%) | $45.26 M(+3.2%) |
| Dec 2010 | $43.86 M(+27.8%) | $16.77 M(+85.1%) | $43.86 M(+23.6%) |
| Sep 2010 | - | $9.06 M(-1.4%) | $35.49 M(-14.9%) |
| Jun 2010 | - | $9.19 M(+4.0%) | $41.69 M(+6.6%) |
| Mar 2010 | - | $8.84 M(+5.2%) | $39.11 M(+10.2%) |
| Dec 2009 | $34.32 M(+54.5%) | $8.40 M(-44.9%) | $35.50 M(+10.7%) |
| Sep 2009 | - | $15.26 M(+130.8%) | $32.07 M(+90.7%) |
| Jun 2009 | - | $6.61 M(+26.4%) | $16.82 M(+64.8%) |
| Mar 2009 | - | $5.23 M(+5.2%) | $10.21 M(+105.2%) |
| Dec 2008 | $22.22 M(+112.3%) | $4.97 M | $4.97 M |
| Dec 2007 | $10.46 M | - | - |
FAQ
- What is Ironwood Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual revenue year-on-year change?
- What is Ironwood Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly revenue year-on-year change?
- What is Ironwood Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals TTM revenue year-on-year change?
What is Ironwood Pharmaceuticals annual revenue?
The current annual revenue of IRWD is $442.74 M
What is the all time high annual revenue for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual revenue is $442.74 M
What is Ironwood Pharmaceuticals annual revenue year-on-year change?
Over the past year, IRWD annual revenue has changed by +$32.14 M (+7.83%)
What is Ironwood Pharmaceuticals quarterly revenue?
The current quarterly revenue of IRWD is $91.59 M
What is the all time high quarterly revenue for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly revenue is $131.17 M
What is Ironwood Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, IRWD quarterly revenue has changed by $0.00 (0.00%)
What is Ironwood Pharmaceuticals TTM revenue?
The current TTM revenue of IRWD is $378.42 M
What is the all time high TTM revenue for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high TTM revenue is $442.74 M
What is Ironwood Pharmaceuticals TTM revenue year-on-year change?
Over the past year, IRWD TTM revenue has changed by $0.00 (0.00%)